Last chance to deliver your research in front of
the global liver community at ILC 2021
Thousands of delegates from all corners of the world have already registered, and many of them are interested in viral hepatitis! Be sure to not miss this last chance to share your research with the global liver community.
Submit your regular or high-profile late-breaker abstract now and connect with your peers! Only by working hand in hand, can we reach our common goal of beating liver disease together.
Submit your regular or high-profile late-breaker abstract
Your research is essential to us beating liver disease together. Are you or your colleagues doing exciting research? Does your company have revealing late-breaker research data from clinical trials to present?
Let the global liver community hear about your latest findings. Make your mark by submitting your abstract to ILC 2021.
Discover key sessions on viral hepatitis at ILC 2021
Research Think Tank:
Understanding immunological and virologic responses in the liver to cure HBV infections
Chaired by: Tobias Böttler (Germany) & Fabien Zoulim (France)
Meet the Experts 1:
Hepatitis C treatment: Are there remaining challenges?
Andrea Cox (USA) & Graham Foster (United Kingdom)
Meet the experts 2:
HBV stopping NUCs before HBs antigens loss
George Papatheodoridis (Greece) & Florian van Bömmel (Germany)
Meet the experts 3:
Management of fulminant and chronic hepatitis E
Harry Dalton (United Kingdom) & Sven Pischke (Germany)
Public health session:
Viral hepatitis elimination: Assessing the progress in 2021
Joint EASL–CDC, ECDC, WHO symposium
Chair: Philippa Easterbrook (Switzerland)
Interactive session 1: From checkpoint-blockade to immuno-suppressants: Management of viral hepatitis in patients with immuno-modulators
Chaired by: Harry Janssen (Canada) & Pietro Lampertico (Italy)
Those abstract presenters who took part in the second round of abstract submission will have ten days after receiving their notification on 18 May to register with early fees.
EASL members will benefit from special registration fees. If you are not a member yet, you can become an EASL member now. It only takes a couple of minutes to fill in the form and start enjoying the numerous benefits of membership.
Visit our eLearning hub, EASL Campus. Create a free account or use the one you have and learn from over 880 resources on viral hepatitis. Start your EASL Campus experience and enjoy reading.
You received this email, because in your previous interaction with EASL, you indicated your speciality and areas of particular interest. To update your preferences, please go to your MyEASL profile.
EASL, The Home of Hepatology
7 rue Daubin, 1203 Geneva, Switzerland
